NCT01372319View on ClinicalTrials.gov

Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

April 30, 2013

Conditions
Glaucoma
Trial Locations (1)

D-72076

Centre for Ophthalmology University of Tübingen, Tübingen

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Hospital Tuebingen

OTHER

NCT01372319 - Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) | Biotech Hunter | Biotech Hunter